A new peer-reviewed paper has been published in the International Journal of Obstetrics and Gynaecology by a team in Israel.
They compared 3 cycles of menstruation before and after 2 doses of the Pfizer mRNA injection in 219 women aged between 18 and 50 who regularly record their periods electronically or on paper.
Although relatively small, the study does have two major strengths: (1) because each woman was recruited before vaccination and acted as their own control there was no selection bias (whereby those affected were more likely to participate) and (2) the results are based on contemporaneous recording of symptoms so should be more reliable.
… The menstrual changes of this frequency (as well as effects seen in other bodily systems) strongly suggest the lipid nanoparticles are travelling throughout the body after injection, and indeed documents the regulatory authorities possess do confirm this is the case, see here or an example of one held by the TGA, Australia’s medicines regulator.
An urgent reappraisal of the safety of these products is surely warranted.